tradingkey.logo
tradingkey.logo
Search

Denmark shares lower at close of trade; OMX Copenhagen 20 down 3.52%

Investing.comNov 15, 2024 5:00 PM
facebooktwitterlinkedin
View all comments0

Investing.com – Denmark equities were lower at the close on Friday, as losses in the Healthcare, Chemicals and Technology sectors propelled shares lower.

At the close in Copenhagen, the OMX Copenhagen 20 lost 3.52% to hit a new 6-month low.

The biggest gainers of the session on the OMX Copenhagen 20 were Vestas Wind Systems A/S (CSE:VWS), which rose 4.29% or 4.30 points to trade at 104.50 at the close. Oersted AS (CSE:ORSTED) added 3.58% or 13.60 points to end at 393.60 and NKT Holding (CSE:NKT) was up 1.05% or 6.00 points to 579.00 in late trade.

Biggest losers included Zealand Pharma A/S (CSE:ZELA), which lost 10.11% or 81.00 points to trade at 720.50 in late trade. Novo Nordisk A/S Class B (CSE:NOVOb) declined 5.36% or 40.30 points to end at 711.00 and Genmab (CSE:GMAB) shed 4.48% or 68.00 points to 1,450.00.

Declining stocks outnumbered rising ones by 79 to 50 and 20 ended unchanged on the Copenhagen Stock Exchange.

In commodities trading, Crude oil for December delivery was down 0.82% or 0.56 to $68.14 a barrel. Meanwhile, Brent oil for delivery in January fell 0.77% or 0.56 to hit $72.00 a barrel, while the December Gold Futures contract fell 0.15% or 3.95 to trade at $2,568.95 a troy ounce.

USD/DKK was down 0.16% to 7.07, while EUR/DKK unchanged 0.01% to 7.46.

The US Dollar Index Futures was down 0.01% at 106.58.

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

tradingkey.logo
* References, analysis, and trading strategies are provided by the third-party provider, Trading Central, and the point of view is based on the independent assessment and judgement of the analyst, without considering the investment objectives and financial situation of the investors.
Risk Warning: Our Website and Mobile App provides only general information on certain investment products. Finsights does not provide, and the provision of such information must not be construed as Finsights providing, financial advice or recommendation for any investment product.
Investment products are subject to significant investment risks, including the possible loss of the principal amount invested and may not be suitable for everyone. Past performance of investment products is not indicative of their future performance.
Finsights may allow third party advertisers or affiliates to place or deliver advertisements on our Website or Mobile App or any part thereof and may be compensated by them based on your interaction with the advertisements.
© Copyright: FINSIGHTS MEDIA PTE. LTD. All Rights Reserved.